Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage Therapy.

MLA

Molica, Matteo, et al. “Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage Therapy.” Mediterranean Journal of Hematology and Infectious Diseases, vol. 16, no. 1, Nov. 2024, p. e2024079. EBSCOhost, https://doi.org/10.4084/MJHID.2024.079.

APA

Molica, M., De Fazio, L., & Rossi, M. (2024). Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage Therapy. Mediterranean Journal of Hematology and Infectious Diseases, 16(1), e2024079. https://doi.org/10.4084/MJHID.2024.079

Chicago

Molica, Matteo, Laura De Fazio, and Marco Rossi. 2024. “Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage Therapy.” Mediterranean Journal of Hematology and Infectious Diseases 16 (1): e2024079. doi:10.4084/MJHID.2024.079.